Sudafed Decongestant Tablets

Sudafed is a well-known brand of decongestant pharmaceuticals, primarily containing pseudohedrine or phenylephrine. The brand was originally developed by Burroughs Wellcome (now part of GlaxoSmithKline) in the United States.

Today, Sudafed is a global household name for sinus and cold relief. While the brand history is tied to major pharmaceutical mergers, it is currently owned by Kenvue, a consumer health company that completed its spin-off from Johnson & Johnson in 2023. Manufacturing occurs in multiple locations across North America, Europe, and Asia to satisfy local regulatory requirements and market demand.